Cargando…
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
Human umbilical cord mesenchymal stem cells (hUC-MSCs) are a promising candidate for spinal cord injury (SCI) repair owing to their advantages of low immunogenicity and easy accessibility over other MSC sources. However, modest clinical efficacy hampered the progression of these cells to clinical tr...
Autores principales: | Cao, Ting-Ting, Chen, Huan, Pang, Mao, Xu, Si-Si, Wen, Hui-Quan, Liu, Bin, Rong, Li-Min, Li, Mang-Mang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820722/ https://www.ncbi.nlm.nih.gov/pubmed/35017439 http://dx.doi.org/10.4103/1673-5374.332151 |
Ejemplares similares
-
Reorganization of the somatosensory pathway after subacute incomplete cervical cord injury
por: Chen, Qian, et al.
Publicado: (2019) -
Recreational Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord
por: Agarwal, Priyal, et al.
Publicado: (2021) -
Subacute Combined Degeneration of the Spinal Cord
por: Hayashi, Tomofumi, et al.
Publicado: (2022) -
Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury
por: CUI, BINGZHOU, et al.
Publicado: (2014) -
Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
por: Zhang, Li-Ting, et al.
Publicado: (2018)